Skip to main content
TipRanks
Go Ultimate75% OFF

Neurotech International (NTI) Ratios

11 Followers

Neurotech International Ratios

AU:NTI's free cash flow for Q4 2026 was AU$-4.19M. For the 2026 fiscal year, AU:NTI's free cash flow was increased by AU$0.00 and operating cash flow was AU$-4.19M. See a summary of the company’s cash flow.

Financial ratios
RatiosJun 26Jun 25Jun 24Jun 23Jun 22
Liquidity Ratios
Current Ratio1.2911.3438.813.943.41
Quick Ratio1.2911.3438.813.943.39
Cash Ratio1.1210.6136.942.243.17
Solvency Ratio-3.06-37.09-16.11-5.78-5.67
Operating Cash Flow Ratio-1.98-31.58-14.60-4.69-4.98
Short-Term Operating Cash Flow Coverage0.000.000.000.000.00
Net Current Asset ValueAU$ 611.14KAU$ 2.95MAU$ 11.90MAU$ 3.96MAU$ 1.43M
Leverage Ratios
Debt-to-Assets Ratio0.000.000.000.000.00
Debt-to-Equity Ratio0.000.000.000.000.00
Debt-to-Capital Ratio0.000.000.000.000.00
Long-Term Debt-to-Capital Ratio0.000.000.000.000.00
Financial Leverage Ratio4.501.101.031.341.41
Debt Service Coverage Ratio0.000.000.000.00-2039.03
Interest Coverage Ratio0.000.000.000.00-2863.46
Debt to Market Cap0.000.000.000.000.00
Interest Debt Per Share0.000.000.000.000.00
Net Debt to EBITDA0.210.281.410.340.56
Profitability Margins
Gross Profit Margin0.00%100.00%-298.88%70.73%-1398.81%
EBIT Margin0.00%-439.21%-420000.82%-150704.28%-8783.84%
EBITDA Margin0.00%-439.20%-419971.12%-150675.01%-8783.57%
Operating Profit Margin0.00%-453.62%-446293.79%-151342.34%-10245.33%
Pretax Profit Margin0.00%-433.60%-420001.07%-150704.28%-10275.40%
Net Profit Margin0.00%-433.60%-258239.99%-130759.17%-8787.42%
Continuous Operations Profit Margin0.00%-433.60%-258239.99%-130759.17%-8787.42%
Net Income Per EBT58.00%100.00%61.49%86.77%85.52%
EBT Per EBIT99.48%95.59%94.11%99.58%100.29%
Return on Assets (ROA)-237.99%-327.10%-41.51%-146.77%-166.20%
Return on Equity (ROE)-1069.89%-358.73%-42.60%-196.67%-235.12%
Return on Capital Employed (ROCE)-1854.26%-375.29%-73.63%-227.63%-274.13%
Return on Invested Capital (ROIC)-1075.52%-375.29%-45.27%-197.50%-234.44%
Return on Tangible Assets-237.99%-327.10%-41.51%-146.77%-166.20%
Earnings Yield-39.51%-68.21%-7.83%-24.39%-6.89%
Efficiency Ratios
Receivables Turnover0.0027.560.010.020.38
Payables Turnover0.000.000.030.001.10
Inventory Turnover0.000.000.000.2279.63
Fixed Asset Turnover0.000.006.796.8314.62
Asset Turnover0.000.750.000.000.02
Working Capital Turnover Ratio0.000.330.000.000.01
Cash Conversion Cycle0.00-278615.6346143.90-252389.80622.60
Days of Sales Outstanding0.0013.2559138.7415776.16949.02
Days of Inventory Outstanding0.000.000.001628.484.58
Days of Payables Outstanding0.00278628.8812994.84269794.44331.00
Operating Cycle0.0013.2559138.7417404.64953.60
Cash Flow Ratios
Operating Cash Flow Per Share-0.00-0.01-0.01-0.01-0.00
Free Cash Flow Per Share-0.00-0.01-0.01-0.01-0.00
Dividend Paid and CapEx Coverage Ratio-844843.000.00-1.00-1263391.00-922.04
Capital Expenditure Coverage Ratio-844843.000.00-1.00-1263391.00-922.04
Operating Cash Flow Coverage Ratio0.000.000.000.000.00
Operating Cash Flow to Sales Ratio0.00-3.69-2340.95-1060.07-77.23
Free Cash Flow Yield-25.53%-58.08%-7.10%-19.77%-6.06%
Valuation Ratios
Price-to-Earnings (P/E) Ratio-2.55-1.47-12.77-4.10-14.52
Price-to-Sales (P/S) Ratio0.006.3632988.565361.791275.65
Price-to-Book (P/B) Ratio27.085.265.448.0634.13
Price-to-Free Cash Flow (P/FCF) Ratio-3.92-1.72-14.09-5.06-16.50
Price-to-Operating Cash Flow Ratio-3.92-1.72-14.09-5.06-16.52
Price-to-Earnings Growth (PEG) Ratio0.06-0.020.30-0.040.21
Enterprise Value Multiple-1.25-1.17-6.44-3.22-13.96
Enterprise Value14.16M12.51M53.13M28.94M46.93M
EV to EBITDA-1.25-1.17-6.44-3.22-13.96
EV to Sales0.005.1227066.254856.531226.51
EV to Free Cash Flow-3.35-1.39-11.56-4.58-15.86
EV to Operating Cash Flow-3.35-1.39-11.56-4.58-15.88
Tangible Book Value Per Share0.000.000.010.000.00
Shareholders’ Equity Per Share0.000.000.010.000.00
Tax and Other Ratios
Effective Tax Rate0.420.000.390.130.14
Revenue Per Share0.000.000.000.000.00
Net Income Per Share-0.01-0.01-0.01-0.01-0.00
Tax Burden0.581.000.610.870.86
Interest Burden0.990.991.001.001.17
Research & Development to Revenue0.004.072673.201082.8667.38
SG&A to Revenue0.001.471211.37271.7416.28
Stock-Based Compensation to Revenue0.000.650.00147.102.19
Income Quality0.650.850.910.810.88

Currency in AUD